Related Experiment Videos
Residual disease in DCIS: an excision too far?
1Lynn Sage Breast Program, Northwestern University, Feinberg School of Medicine, Northwestern Memorial Hospital, Chicago, Illinois 60611, USA.
Cancer Journal (Sudbury, Mass.)
|February 27, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Examining Race and Patient-Reported Outcomes After Contralateral Prophylactic Mastectomy with Reconstruction.
Annals of surgical oncology·2023
Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores.
Breast cancer research and treatment·2023
Is Axillary Staging Obsolete in Early Breast Cancer?
Surgical oncology clinics of North America·2023
Does Non-Classic Lobular Carcinoma In Situ at the Lumpectomy Margin Increase Local Recurrence?
Annals of surgical oncology·2023
Basic and Translational Research Advances in NSCLC.
Cancer journal (Sudbury, Mass.)·2026
Medical Management of Non-Small Cell Lung Cancer Brain Metastases in the Modern Era.
Cancer journal (Sudbury, Mass.)·2026
Optimizing the Care of Patients With Locally Advanced NSCLC With Multimodality Therapy.
Cancer journal (Sudbury, Mass.)·2026
Early-Stage NSCLC: Novel Surgical Techniques and Neoadjuvant, Adjuvant, and Perioperative Therapies.
Cancer journal (Sudbury, Mass.)·2026
Lung Cancer Biomarker Testing: IHC, Tissue Genomics, Digital Pathology, and ctDNA.
Cancer journal (Sudbury, Mass.)·2026
The Quest to Cure Metastatic Non-Small Cell Lung Cancer With Immunotherapy.
Cancer journal (Sudbury, Mass.)·2026
Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.
The journal of vascular access·2026
Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.
Indian journal of pharmacology·2026
Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.
Expert review of pharmacoeconomics & outcomes research·2026